LLY Price / Book | ELI LILLY AND COMPANY

ELI LILLY & Co Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

ELI LILLY & Co price/book ratio for the quarter ending 2025-09-30 was 30.28, a 48.51% decline year-over-year.
ELI LILLY & Co price/book ratio for the quarter ending 2025-06-30 was 40.25, a 36.22% decline year-over-year.
ELI LILLY & Co price/book ratio for the quarter ending 2025-03-31 was 49.42, a 13.78% decline year-over-year.
ELI LILLY & Co price/book ratio for the quarter ending 2024-12-31 was 51.35, a 0.81% increase year-over-year.
ELI LILLY & Co price/book ratio for fiscal 2025 was 30.28.
ELI LILLY & Co price/book ratio for fiscal 2024 was 51.35, a 0.81% increase from fiscal 2023.
ELI LILLY & Co price/book ratio for fiscal 2023 was 50.94, a 57.90% increase from fiscal 2022.
ELI LILLY & Co price/book ratio for fiscal 2022 was 32.26, a 11.77% increase from fiscal 2021.

Available history: 2009-09-30 to 2025-09-30
Data captured: 2025-09-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2025-09-30	30.28	$722.1B	$23.85B
2025-06-30	40.25	$738.56B	$18.35B
2025-03-31	49.42	$783.1B	$15.85B
2024-12-31	51.35	$732.87B	$14.27B
2024-09-30	58.8	$842.02B	$14.32B
2024-06-30	63.11	$860.48B	$13.64B
2024-03-31	57.31	$739.19B	$12.9B
2023-12-31	50.94	$553.37B	$10.86B
2023-09-30	45.09	$509.89B	$11.31B
2023-06-30	39.93	$445.19B	$11.15B
2023-03-31	28.89	$326.35B	$11.29B
2022-12-31	32.26	$347.61B	$10.78B
2022-09-30	30.22	$307.24B	$10.17B
2022-06-30	35.58	$308.07B	$8.66B
2022-03-31	28.82	$272.72B	$9.46B
2021-12-31	28.86	$264.23B	$9.15B
2021-09-30	27.79	$221.02B	$7.95B
2021-06-30	33.03	$220.12B	$6.66B
2021-03-31	25.22	$179.05B	$7.1B
2020-12-31	27.73	$161.51B	$5.83B
2020-09-30	28.34	$141.58B	$5B
2020-06-30	36.76	$157.03B	$4.27B
2020-03-31	41.5	$132.67B	$3.2B
2019-12-31	46.75	$126.19B	$2.7B
2019-09-30	31.18	$107.96B	$3.46B
2019-06-30	37.64	$107.56B	$2.86B
2019-03-31	52.38	$134.36B	$2.57B
2018-12-31	11.24	$122.58B	$10.91B
2018-09-30	8.14	$115.25B	$14.15B
2018-06-30	7.97	$92.62B	$11.62B
2018-03-31	5.81	$84.77B	$14.59B
2017-12-31	7.97	$93B	$11.67B
2017-09-30	6.3	$94.18B	$14.96B
2017-06-30	6.41	$90.81B	$14.17B
2017-03-31	6.58	$92.8B	$14.1B
2016-12-31	5.77	$81.2B	$14.08B
2016-09-30	5.67	$88.59B	$15.62B
2016-06-30	5.93	$86.93B	$14.66B
2016-03-31	5.3	$79.65B	$15.03B
2015-12-31	6.4	$93.37B	$14.59B
2015-09-30	6.09	$92.77B	$15.24B
2015-06-30	6.3	$92.65B	$14.71B
2015-03-31	5.4	$80.72B	$14.95B
2014-12-31	4.99	$76.82B	$15.39B
2014-09-30	4.1	$72.46B	$17.68B
2014-06-30	3.87	$69.6B	$17.99B
2014-03-31	3.59	$65.91B	$18.35B
2013-12-31	3.26	$57.46B	$17.64B
2013-09-30	3.36	$56.7B	$16.9B
2013-06-30	3.63	$55.34B	$15.24B
2013-03-31	4.31	$64.42B	$14.96B
2012-12-31	3.87	$57.23B	$14.77B
2012-09-30	3.43	$55.02B	$16.06B
2012-06-30	3.48	$49.79B	$14.31B
2012-03-31	3.15	$46.73B	$14.82B
2011-12-31	3.55	$48.12B	$13.54B
2011-09-30	2.84	$42.8B	$15.06B
2011-06-30	3.04	$43.45B	$14.28B
2011-03-31	2.92	$40.72B	$13.93B
2010-12-31	3.26	$40.41B	$12.41B
2010-09-30	3.4	$42.12B	$12.41B
2010-06-30	3.77	$38.63B	$10.24B
2010-03-31	3.99	$41.77B	$10.46B
2009-12-31	4.31	$41.03B	$9.53B
2009-09-30	3.83	$37.95B	$9.91B

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2025-09-30	30.28	$722.1B	$23.85B
2024-12-31	51.35	$732.87B	$14.27B
2023-12-31	50.94	$553.37B	$10.86B
2022-12-31	32.26	$347.61B	$10.78B
2021-12-31	28.86	$264.23B	$9.15B
2020-12-31	27.73	$161.51B	$5.83B
2019-12-31	46.75	$126.19B	$2.7B
2018-12-31	11.24	$122.58B	$10.91B
2017-12-31	7.97	$93B	$11.67B
2016-12-31	5.77	$81.2B	$14.08B
2015-12-31	6.4	$93.37B	$14.59B
2014-12-31	4.99	$76.82B	$15.39B
2013-12-31	3.26	$57.46B	$17.64B
2012-12-31	3.87	$57.23B	$14.77B
2011-12-31	3.55	$48.12B	$13.54B
2010-12-31	3.26	$40.41B	$12.41B
2009-12-31	4.31	$41.03B	$9.53B

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Akari Therapeutics Plc (AKTX)		$1,527.991B	-47,921.42
JOHNSON & JOHNSON (JNJ)	United States	$652.528B	29.10
AbbVie Inc. (ABBV)	United States	$468.180B	70.37
Merck & Co., Inc. (MRK)	United States	$365.215B	99.96
ABBOTT LABORATORIES (ABT)	United States	$176.045B	28.47
PFIZER INC (PFE)	United States	$162.042B	31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)	United States	$132.481B	28.56
BRISTOL MYERS SQUIBB CO (BMY)	United States	$125.637B	12.67
REGENERON PHARMACEUTICALS, INC. (REGN)	United States	$74.751B	21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)	United States	$33.420B	54.94